Controlling pathogenic inflammation to fungi

References

• Romani L. Chapter overview of the fungal pathogens. In: Immunology of Infectious Diseases. Kaufmann SHE, Sher A, Ahmed R (Eds). ASM Press, DC, USA 25–37 (2001).
   Google Scholar
• Denning DW, O’Driscoll BR, Hogaboam CM, Bowyer P, Niven RM. The link between fungi and severe asthma: a summary of the evidence. Eur. Respir. J.27(3), 615–626 (2006).
   PubMed Web of Science ®Google Scholar
• Dan JM, Levitz SM. Prospects for development of vaccines against fungal diseases. Drug Resist. Update9(3), 105–110 (2006).
   PubMed Web of Science ®Google Scholar
• Cassone A, Torosantucci A. Opportunistic fungi and fungal infections: the challenge of a single, general antifungal vaccine. Expert Rev. Vaccines5(6), 859–867 (2006).
   PubMed Web of Science ®Google Scholar
• Cutler JE, Deepe GS Jr, Klein BS. Advances in combating fungal diseases: vaccines on the threshold. Nat. Rev. Microbiol.5(1), 13–28 (2007).
   PubMed Web of Science ®Google Scholar
• Segal BH, Kwon-Chung J, Walsh TJ et al. Immunotherapy for fungal infections. Clin. Infect. Dis.42(4), 507–515 (2006).
   PubMed Web of Science ®Google Scholar
• Garbino J, Katragkou A, Roilides E. Immunomodulatory therapy in yeast infections. Expert Rev. Anti Infect. Ther.5(1), 129–140 (2007).
   PubMed Web of Science ®Google Scholar
• Romani L. Immunity to fungal infections. Nat. Rev. Immunol.4(1), 1–23 (2004).
   PubMed Web of Science ®Google Scholar
• Romani L. Innate immunity to fungi: the art of speed and specificity. In: Pathogenic Fungi. Host Interactions and Emerging Strategies for Control. San-Blas G, Calderone RA (Eds). Caister Academic Press, Norfolk, UK 167–214 (2004).
   Google Scholar
• Mansour MK, Levitz SM. Interactions of fungi with phagocytes. Curr. Opin. Microbiol.5(4), 359–365 (2002).
   PubMed Web of Science ®Google Scholar
• Bromuro C, Torosantucci A, Chiani P et al. Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated candidiasis in recipients of a Candida albicans vaccine. Infect. Immun.70(10), 5462–5470 (2002).
   PubMed Web of Science ®Google Scholar
• Pachl J, Achl J, Svoboda P et al. A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis. Clin. Infect. Dis.42(10), 1404–1413 (2006).
   PubMed Web of Science ®Google Scholar
• Montagnoli C, Bozza S, Bacci A et al. A role for antibodies in the generation of memory antifungal immunity. Eur. J. Immunol.33(5), 1193–1204 (2003).
   PubMed Web of Science ®Google Scholar
• Romani L, Mencacci A, Cenci E et al. Neutrophils and the adaptive immune response to Candida albicans. Res. Immunol.147(8–9), 512–518 (1996).
   PubMedGoogle Scholar
• Akira S, Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol.4(7), 499–511 (2004).
   PubMed Web of Science ®Google Scholar
• Levitz SM. Interactions of Toll-like receptors with fungi. Microbes Infect.6(15), 1351–1355 (2004).
   PubMed Web of Science ®Google Scholar
• Netea MG, Gow NA, Munro CA et al. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J. Clin. Invest.116(6), 1642–1650 (2006).
   PubMed Web of Science ®Google Scholar
• Bellocchio S, Montagnoli C, Bozza S et al. The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J. Immunol.172(5), 3059–3069 (2004).
   PubMed Web of Science ®Google Scholar
• Bellocchio S, Moretti S, Perruccio K et al. TLRs govern neutrophil activity in aspergillosis. J. Immunol.173(12), 7406–7415 (2004).
   PubMed Web of Science ®Google Scholar
• Romani L, Puccetti P. Dendritic cells in immunity and vaccination against fungi. In: Dendritic Cells. Biology, Diseases and Therapies (Vol. 2). Lutz MB, Steinkasser A (Eds). Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany 915–930 (2006).
   Google Scholar
• Buentke E, Scheynius A. Dendritic cells and fungi. AMPIS111(7–8), 789–796 (2003).
   Google Scholar
• Biondo C, Midiri A, Messina L et al. MyD88 and TLR2, but not TLR4, are required for host defense against Cryptococcus neoformans. Eur. J. Immunol.35(3), 870–878 (2005).
   PubMed Web of Science ®Google Scholar
• Rivera A, Ro G, Van Epps HL, Simpson T et al. Innate immune activation and CD4+ T cell priming during respiratory fungal infection. Immunity25(4), 665–675 (2006).
   PubMed Web of Science ®Google Scholar
• Netea MG, Warris A, Van der Meer JW et al. Aspergillus fumigatus evades immune recognition during germination through loss of Toll-like receptor-4-mediated signal transduction. J. Infect. Dis.188(2), 320–326 (2003).
   PubMed Web of Science ®Google Scholar
• Bozza S, Gaziano R, Lipford GB et al. Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants. Microbes Infect.4(13), 1281–1290 (2002).
   PubMed Web of Science ®Google Scholar
• Edwards L, Williams AE, Krieg AM et al. Stimulation via Toll-like receptor 9 reduces Cryptococcus neoformans-induced pulmonary inflammation in an IL-12-dependent manner. Eur. J. Immunol.35(1), 273–281 (2004).
   Web of Science ®Google Scholar
• Netea MG, Van der Meer JW, Kullberg BJ. Toll-like receptors as an escape mechanism from the host defense. Trends Microbiol.12(11), 484–488 (2004).
   PubMed Web of Science ®Google Scholar
• De Luca A, Montagnoli C, Zelante T et al. Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc. J. Immunol.179(9), 5999–6008 (2007).
   PubMed Web of Science ®Google Scholar
• Kesh S, Mensah NY, Peterlongo P et al. TLR1 and TLR6 polymorphisms are associated with susceptibility to invasive aspergillosis after allogeneic stem cell transplantation. Ann. NY Acad. Sci.1062, 95–103 (2005).
   PubMed Web of Science ®Google Scholar
• Brown GD. Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat. Rev. Immunol.6(1), 33–43 (2006).
   PubMed Web of Science ®Google Scholar
• Moraes-Vasconcelos D, Grumach AS, Yamaguti A et al. Paracoccidioides brasiliensis disseminated disease in a patient with inherited deficiency in the β1 subunit of the interleukin (IL)-12/IL-23 receptor. Clin. Infect. Dis.41(4), e31–e37 (2005).
   PubMed Web of Science ®Google Scholar
• Zerbe CS, Holland SM. Disseminated histoplasmosis in persons with interferon-γ receptor 1 deficiency. Clin. Infect. Dis.41(4), e38–e41 (2005).
   PubMed Web of Science ®Google Scholar
• Lilic D, Gravenor I, Robson N et al. Deregulated production of protective cytokines in response to Candida albicans infection in patients with chronic mucocutaneous candidiasis. Infect. Immun.71(10), 5690–5699 (2003).
   PubMed Web of Science ®Google Scholar
• Han J, Ulevitch RJ. Limiting inflammatory responses during activation of innate immunity. Nat. Immunol.6(12), 1198–205 (2005).
   PubMed Web of Science ®Google Scholar
• Cheng VC, Yuen KY, Chan WM et al. Immunorestitution disease involving the innate and adaptive response. Clin. Infect. Dis.30(6), 882–892 (2000).
   PubMed Web of Science ®Google Scholar
• Singh N, Perfect JR. Immune reconstitution syndrome associated with opportunistic mycoses. Lancet Infect. Dis.7(6), 395–401 (2007).
   PubMed Web of Science ®Google Scholar
• Antachopoulos C, Walsh TJ, Roilides E. Fungal infections in primary immunodeficiencies. Eur. J. Pediatr.166(11), 1099–1017 (2007).
   PubMed Web of Science ®Google Scholar
• Holland SM, Deleo FR, Elloumi HZ et al. STAT3 mutations in the hyper-IgE syndrome. N. Engl. J. Med.357(16), 1608–1619 (2007).
   PubMed Web of Science ®Google Scholar
• Eppinger TM, Greenberger PA, White DA et al. Sensitization to Aspergillus species in the congenital neutrophil disorders chronic granulomatous disease and hyper-IgE syndrome. J. Allergy Clin. Immunol.104(6), 1265–1272 (1999).
   PubMed Web of Science ®Google Scholar
• Stergiopoulou T, Meletiadis J, Roilides E et al. Host-dependent patterns of tissue injury in invasive pulmonary aspergillosis. Am. J. Clin. Pathol.127(3), 349–355 (2007).
   PubMed Web of Science ®Google Scholar
• Ryan KR, Lawson CA, Lorenzi AR et al. CD4+CD25+ T-regulatory cells are decreased in patients with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy. J. Allergy Clin. Immunol.116(5), 1158–1159 (2005).
   PubMed Web of Science ®Google Scholar
• Lilic D. New perspectives on the immunology of chronic mucocutaneous candidiasis. Curr. Opin. Infect. Dis.15(2), 143–147 (2002).
   PubMed Web of Science ®Google Scholar
• Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Inflammatory response and clinical course of adult patients with nosocomial bloodstream infections caused by Candida spp. Clin. Microbiol. Infect.12(2), 170–177 (2006).
   PubMed Web of Science ®Google Scholar
• Ortega M, Rovira M, Filella X et al. Prospective evaluation of procalcitonin in adults with non-neutropenic fever after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant.37(5), 499–502 (2006).
   PubMed Web of Science ®Google Scholar
• Schubert MS. Allergic fungal sinusitis. Clin. Rev. Allergy Immunol.30(3), 205–216 (2006).
   PubMed Web of Science ®Google Scholar
• Khasawneh F, Mohamad T, Moughrabieh MK et al. Isolation of Aspergillus in critically ill patients: a potential marker of poor outcome. J. Crit. Care21(4), 322–327 (2006).
   PubMed Web of Science ®Google Scholar
• Dong C. Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat. Rev. Immunol.6(4), 329–333 (2006).
   PubMed Web of Science ®Google Scholar
• Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity24(2), 179–189 (2006).
   PubMed Web of Science ®Google Scholar
• Mangan PR, Harrington LE, O’Quinn DB et al. Transforming growth factor-β induces development of the T(H)17 lineage. Nature441(7090), 231–234 (2006).
   PubMed Web of Science ®Google Scholar
• Trinchieri G, Pflanz S, Kastelein RA. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity19(5), 641–644 (2003).
   PubMed Web of Science ®Google Scholar
• Bettelli E, Oukka M, Kuchroo VK. T(H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol.8(4), 345–350 (2007).
   PubMed Web of Science ®Google Scholar
• Hunter CA. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol.5(7), 521–531 (2005).
   PubMed Web of Science ®Google Scholar
• Bowman EP, Chackerian AA, Cua DJ. Rationale and safety of anti-interleukin-23 and anti-interleukin-17A therapy. Curr. Opin. Infect. Dis.19(3), 245–252 (2006).
   PubMed Web of Science ®Google Scholar
• Acosta-Rodriguez EV, Rivino L et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol.8(6), 639–646 (2007).
   PubMed Web of Science ®Google Scholar
• Leibundgut-Landmann S, Gross O, Robinson MJ et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol.8(6), 630–638 (2007).
   PubMed Web of Science ®Google Scholar
• Huang W, Na L, Fidel PL, Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis.190(3), 624–631 (2004).
   PubMed Web of Science ®Google Scholar
• Rudner XL, Happel KI, Young EA, Shellito JE. Interleukin-23 (IL-23)–IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect. Immun.75(6), 3055–3061 (2007).
   PubMed Web of Science ®Google Scholar
• Zelante T, De Luca A, Bonifazi P et al. The IL17 pathway promotes inflammation and impairs antifungal immune resistance. Eur. J. Immunol.37(10), 2695–2706 (2007).
   PubMed Web of Science ®Google Scholar
• Bozza S, Fallarino F, Pitzurra L et al. A crucial role for tryptophan catabolism at the host/Candida albicans interface. J. Immunol.174(5), 2910–2918 (2005).
   PubMed Web of Science ®Google Scholar
• Linden A, Laan M, Anderson GP. Neutrophils, interleukin-17A and lung disease. Eur Respir. J.25(1), 159–172 (2005).
   PubMed Web of Science ®Google Scholar
• Nakae S, Komiyama Y, Nambu A et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity17(3), 375–387 (2002).
   PubMed Web of Science ®Google Scholar
• Hida S, Nagi-Miura N, Adachi Y, Ohno N. β-glucan derived from zymosan acts as an adjuvant for collagen-induced arthritis. Microbiol. Immunol.50(6), 453–461 (2006).
   PubMed Web of Science ®Google Scholar
• Yoshitomi H, Sakaguchi N, Kobayashi K et al. A role for fungal β-glucans and their receptor dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J. Exp. Med.201(6), 949–960 (2005).
   PubMed Web of Science ®Google Scholar
• Nisini R, Torosantucci A, Romagnoli G et al. β-glucan of Candida albicans cell wall causes the subversion of human monocyte differentiation into dendritic cells. J. Leukoc. Biol.82(5), 1136–1142 (2007).
   PubMed Web of Science ®Google Scholar
• Dillon S, Agrawal S, Banerjee K et al. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J. Clin. Invest.116(4), 916–928 (2006).
   PubMed Web of Science ®Google Scholar
• Mellor AL, Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol.4(10), 762–774 (2004).
   PubMed Web of Science ®Google Scholar
• Romani L, Puccetti P. Protective tolerance to fungi: the role of IL-10 and tryptophan catabolism. Trends Microbiol.14(4), 183–189 (2006).
   PubMed Web of Science ®Google Scholar
• O’Garra A, Vieira P. Regulatory T cells and mechanisms of immune system control. Nat. Med.10(8), 801–805 (2004).
   PubMed Web of Science ®Google Scholar
• Coombes JL, Siddiqui KR, Arancibia-Carcamo CV et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β and retinoic acid dependent mechanism. J. Exp. Med.204(8), 1757–1764 (2007).
   PubMed Web of Science ®Google Scholar
• Hori S, Carvalho TL, Demengeot J. CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur. J. Immunol.32(5), 1282–1291 (2002).
   PubMed Web of Science ®Google Scholar
• Montagnoli C, Bacci A, Bozza S et al. B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J. Immunol.169(11), 6298–6308 (2002).
   PubMed Web of Science ®Google Scholar
• Montagnoli C, Fallarino F, Gaziano R et al. Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism. J. Immunol.176(3), 1712–1723 (2006).
   PubMed Web of Science ®Google Scholar
• McKinley L, Logar AJ, McAllister F et al. Regulatory T cells dampen pulmonary inflammation and lung injury in an animal model of pneumocystis pneumonia. J. Immunol.177(9), 6215–6226 (2006).
   PubMed Web of Science ®Google Scholar
• Cavassani KA, Campanelli AP, Moreira AP et al. Systemic and local characterization of regulatory T cells in a chronic fungal infection in humans. J. Immunol.177(9), 5811–5818 (2006).
   PubMed Web of Science ®Google Scholar
• Kekalainen E, Tuovinen H, Joensuu J et al. A defect of regulatory T cells in patients with autoimmune polyendocrinopathy– candidiasis–ectodermal dystrophy. J. Immunol.178(2), 1208–1215 (2007).
   PubMed Web of Science ®Google Scholar
• Grohmann U, Volpi C, Fallarino F et al. Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nat. Med.13(5), 579–586 (2007).
   PubMed Web of Science ®Google Scholar
• Belladonna ML, Grohmann U, Guidetti P et al. Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. J. Immunol.177(1), 130–137 (2006).
   PubMed Web of Science ®Google Scholar
• Fallarino F, Vacca C, Orabona C et al. Functional expression of indoleamine 2,3-dioxygenase by murine CD8 α+ dendritic cells. Int. Immunol.14(1), 65–68 (2002).
   PubMed Web of Science ®Google Scholar
• Munn DH, Sharma MD, Lee JR et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science297(5588), 1867–1870 (2002).
   PubMed Web of Science ®Google Scholar
• Grohmann U, Fallarino F, Puccetti P. Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol.24(5), 242–248 (2003).
   PubMed Web of Science ®Google Scholar
• Fallarino F, Grohmann U, You S et al. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor ζ-chain and induce a regulatory phenotype in naive T cells. J. Immunol.176(11), 6752–6761 (2006).
   PubMed Web of Science ®Google Scholar
• Colonna M, Trinchieri G, Liu YJ. Plasmacytoid dendritic cells in immunity. Nat. Immunol.5(12), 1219–1226 (2004).
   PubMed Web of Science ®Google Scholar
• Ito M, Ogawa K, Takeuchi K et al. Gene expression of enzymes for tryptophan degradation pathway is upregulated in the skin lesions of patients with atopic dermatitis or psoriasis. J. Dermatol. Sci.36(3), 157–164 (2004).
   PubMed Web of Science ®Google Scholar
• Le AV, Broide DH. Indoleamine-2,3-dioxygenase modulation of allergic immune responses. Curr. Allergy Asthma Rep.6(1), 27–31 (2006).
   PubMed Web of Science ®Google Scholar
• Gurtner GJ, Newberry RD, Schloemann SR, McDonald KG, Stenson WF. Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice. Gastroenterology125(6), 1762–1773 (2003).
   PubMed Web of Science ®Google Scholar
• Liu AH, Leung DY. Renaissance of the hygiene hypothesis. J. Allergy Clin. Immunol.117(5), 1063–1066 (2006).
   PubMed Web of Science ®Google Scholar
• Puccetti P, Grohmann U. IDO and regulatory T cells: a role for reverse signaling and non-canonical NF-κB activation. Nat. Rev. Immunol.7(10), 817–823 (2007).
   PubMed Web of Science ®Google Scholar
• Romani L, Bistoni F, Perruccio K et al. Thymosin α1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance. Blood108(7), 2265–2274 (2006).
   PubMed Web of Science ®Google Scholar
• Romani L, Bistoni F, Puccetti P. Fungi, dendritic cells and receptors: a host perspective of fungal virulence. Trends Microbiol.10(11), 508–514 (2002).
   PubMed Web of Science ®Google Scholar
• Noverr MC, Huffnagle GB. Does the microbiota regulate immune responses outside the gut? Trends Microbiol.12(12), 562–568 (2004).
   PubMed Web of Science ®Google Scholar
• Mencacci A, Cenci E, Bacci A, Montagnoli C, Bistoni F, Romani L. Cytokines in candidiasis and aspergillosis. Curr. Pharm. Biotechnol.1(3), 235–251 (2000).
   PubMedGoogle Scholar
• Kawakami K. Promising immunotherapies with Th1-related cytokines against infectious diseases. J. Infect. Chemother.9(3), 201–209 (2003).
   PubMedGoogle Scholar
• Roilides E, Lyman CA, Panagopoulou P, Chanock S. Immunomodulation of invasive fungal infections. Infect. Dis. Clin. North Am.17(1), 193–219 (2003).
   PubMed Web of Science ®Google Scholar
• Koguchi Y, Kawakami K. Cryptococcal infection and Th1-Th2 cytokine balance. Int. Rev. Immunol.21(4–5), 423–438 (2002).
   PubMedGoogle Scholar
• Pirofski LA, Casadevall A. Immunomodulators as an antimicrobial tool. Curr. Opin. Microbiol.9(5), 489–495 (2006).
   PubMed Web of Science ®Google Scholar